Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready-to-use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males.
Hompesch M, Hawryluk A, Hernandez M, Uchil B, Wilmington A, Peterson L. Hompesch M, et al. Diabetes Obes Metab. 2021 Dec;23(12):2679-2686. doi: 10.1111/dom.14520. Epub 2021 Sep 8. Diabetes Obes Metab. 2021. PMID: 34378307 Free PMC article. Clinical Trial.
Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus.
Morrow LA, Leonsson-Zachrisson M, Ericsson H, Wollbratt M, Knutsson M, Hompesch M, Norjavaara E. Morrow LA, et al. Among authors: hompesch m. Diabetes Obes Metab. 2012 Dec;14(12):1114-22. doi: 10.1111/j.1463-1326.2012.01661.x. Epub 2012 Jul 31. Diabetes Obes Metab. 2012. PMID: 22775976 Clinical Trial.
Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
Krentz AJ, Morrow L, Petersson M, Norjavaara E, Hompesch M. Krentz AJ, et al. Among authors: hompesch m. Diabetes Obes Metab. 2014 Nov;16(11):1096-101. doi: 10.1111/dom.12323. Epub 2014 Jul 3. Diabetes Obes Metab. 2014. PMID: 24909093 Clinical Trial.
LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.
Wronkowitz N, Hartmann T, Görgens SW, Dietze-Schroeder D, Indrakusuma I, Choi IY, Park SH, Lee YM, Kwon SC, Kang Y, Hompesch M, Eckel J. Wronkowitz N, et al. Among authors: hompesch m. Diabetes Obes Metab. 2017 Dec;19(12):1722-1731. doi: 10.1111/dom.13006. Epub 2017 Jul 13. Diabetes Obes Metab. 2017. PMID: 28497570
70 results